3,877
Views
83
CrossRef citations to date
0
Altmetric
Original Articles

Human aflatoxin exposure in Kenya, 2007: a cross-sectional study

, , , , , , , , , , & show all
Pages 1322-1331 | Received 14 Jan 2013, Accepted 20 Mar 2013, Published online: 14 Jun 2013
 

Abstract

Aflatoxins contaminate approximately 25% of agricultural products worldwide. They can cause liver failure and liver cancer. Kenya has experienced multiple aflatoxicosis outbreaks in recent years, often resulting in fatalities. However, the full extent of aflatoxin exposure in Kenya has been unknown. Our objective was to quantify aflatoxin exposure across Kenya. We analysed aflatoxin levels in serum specimens from the 2007 Kenya AIDS Indicator Survey – a nationally representative, cross-sectional serosurvey. KAIS collected 15,853 blood specimens. Of the 3180 human immunodeficiency virus-negative specimens with ≥1 mL sera, we randomly selected 600 specimens stratified by province and sex. We analysed serum specimens for aflatoxin albumin adducts by using isotope dilution MS/MS to quantify aflatoxin B1-lysine, and normalised with serum albumin. Aflatoxin concentrations were then compared by demographic, socioeconomic and geographic characteristics. We detected serum aflatoxin B1-lysine in 78% of serum specimens (range = <LOD–211 pg/mg albumin, median = 1.78 pg/mg albumin). Aflatoxin exposure did not vary by sex, age group, marital status, religion or socioeconomic characteristics. Aflatoxin exposure varied by province (p < 0.05); it was highest in Eastern (median = 7.87 pg/mg albumin) and Coast (median = 3.70 pg/mg albumin) provinces and lowest in Nyanza (median = <LOD) and Rift Valley (median = 0.70 pg/mg albumin) provinces. Our findings suggest that aflatoxin exposure is a public health problem throughout Kenya, and it could be substantially impacting human health. Wide-scale, evidence-based interventions are urgently needed to decrease exposure and subsequent health effects.

Acknowledgements

This study was funded through the United States President’s Emergency Plan for AIDS Relief and the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. We thank the following organisations for their assistance in completing this research: the Government of Kenya, Kenya Ministry of Public Health and Sanitation, Kenya National HIV Reference Laboratory, CDC Global Disease Detection Division and the CDC Division of Global HIV/AIDS within CDC-Kenya.

Declaration of interest: The sponsor of the study had some role in study design and data collection; they had no role in data analysis, data interpretation, or manuscript preparation. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. We declare that we have no conflicts of interest.

Notes

Mamo Umuro Abudo, Willis Akhwale, and Shahnaaz K. Sharif waive their assertion of copyright but not their right to be named as authors of the paper.